BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 12880773)

  • 1. Purification and characterization of osteopontin from human milk.
    Sørensen S; Justesen SJ; Johnsen AH
    Protein Expr Purif; 2003 Aug; 30(2):238-45. PubMed ID: 12880773
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improved immunohistochemical staining of osteopontin (OPN) in paraffin-embedded archival bone specimens following antigen retrieval: anti-human OPN antibody recognizes multiple molecular forms.
    Devoll RE; Pinero GJ; Appelbaum ER; Dul E; Troncoso P; Butler WT; Farach-Carson MC
    Calcif Tissue Int; 1997 Apr; 60(4):380-6. PubMed ID: 9075637
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Isolation and biological properties of osteopontin from bovine milk.
    Bayless KJ; Davis GE; Meininger GA
    Protein Expr Purif; 1997 Apr; 9(3):309-14. PubMed ID: 9126601
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [A study on development of enzyme immunoassay of human osteopontin: molecular fragility of serum osteopontin].
    Fujisaki S
    Hokkaido Igaku Zasshi; 2000 Jan; 75(1):45-52. PubMed ID: 10736760
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Structural characteristics of osteopontin for calcium oxalate crystal].
    Umekawa T
    Nihon Hinyokika Gakkai Zasshi; 1999 Mar; 90(3):436-44. PubMed ID: 10349302
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Posttranslational modifications of bovine osteopontin: identification of twenty-eight phosphorylation and three O-glycosylation sites.
    Sørensen ES; Højrup P; Petersen TE
    Protein Sci; 1995 Oct; 4(10):2040-9. PubMed ID: 8535240
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Osteopontin posttranslational modifications, possibly phosphorylation, are required for in vitro bone resorption but not osteoclast adhesion.
    Razzouk S; Brunn JC; Qin C; Tye CE; Goldberg HA; Butler WT
    Bone; 2002 Jan; 30(1):40-7. PubMed ID: 11792563
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibodies to different peptides in osteopontin reveal complexities in the various secreted forms.
    Kon S; Maeda M; Segawa T; Hagiwara Y; Horikoshi Y; Chikuma S; Tanaka K; Rashid MM; Inobe M; Chambers AF; Uede T
    J Cell Biochem; 2000 Apr; 77(3):487-98. PubMed ID: 10760956
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence that a non-RGD domain in rat osteopontin is involved in cell attachment.
    van Dijk S; D'Errico JA; Somerman MJ; Farach-Carson MC; Butler WT
    J Bone Miner Res; 1993 Dec; 8(12):1499-506. PubMed ID: 8304052
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proteomic analysis and immunodetection of the bovine milk osteopontin isoforms.
    Bissonnette N; Dudemaine PL; Thibault C; Robitaille G
    J Dairy Sci; 2012 Feb; 95(2):567-79. PubMed ID: 22281321
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mapping of functional epitopes of osteopontin by monoclonal antibodies raised against defined internal sequences.
    Kon S; Yokosaki Y; Maeda M; Segawa T; Horikoshi Y; Tsukagoshi H; Rashid MM; Morimoto J; Inobe M; Shijubo N; Chambers AF; Uede T
    J Cell Biochem; 2002; 84(2):420-32. PubMed ID: 11787071
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Calcium phosphate crystal-associated proteins: alpha2-HS-glycoprotein, prothrombin F1, and osteopontin.
    Nishio S; Hatanaka M; Takeda H; Aoki K; Iseda T; Iwata H; Yokoyama M
    Mol Urol; 2000; 4(4):383-90. PubMed ID: 11156706
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cell migration promoted by a potent GRGDS-containing thrombin-cleavage fragment of osteopontin.
    Senger DR; Perruzzi CA
    Biochim Biophys Acta; 1996 Nov; 1314(1-2):13-24. PubMed ID: 8972713
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The carboxyl-terminal fragment of osteopontin suppresses arginine-glycine-asparatic acid-dependent cell adhesion.
    Takahashi K; Takahashi F; Tanabe KK; Takahashi H; Fukuchi Y
    Biochem Mol Biol Int; 1998 Dec; 46(6):1081-92. PubMed ID: 9891840
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of various epitopes of murine osteopontin by monoclonal antibodies.
    Hotta H; Kon S; Katagiri YU; Tosa N; Tsukamoto T; Chambers AF; Uede T
    Biochem Biophys Res Commun; 1999 Apr; 257(1):6-11. PubMed ID: 10092501
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of osteopontin in modulation of hydroxyapatite formation.
    Hunter GK
    Calcif Tissue Int; 2013 Oct; 93(4):348-54. PubMed ID: 23334303
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protein kinases of cultured osteoblasts: selectivity for the extracellular matrix proteins of bone and their catalytic competence for osteopontin.
    Salih E; Ashkar S; Gerstenfeld LC; Glimcher MJ
    J Bone Miner Res; 1996 Oct; 11(10):1461-73. PubMed ID: 8889846
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of two phosphorylation motifs in bovine osteopontin.
    Sørensen ES; Petersen TE
    Biochem Biophys Res Commun; 1994 Jan; 198(1):200-5. PubMed ID: 8292023
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low-molecular-weight variants of osteopontin generated by serine proteinases in urine of patients with kidney stones.
    Bautista DS; Denstedt J; Chambers AF; Harris JF
    J Cell Biochem; 1996 Jun; 61(3):402-9. PubMed ID: 8761944
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of a macromolecular crystal growth inhibitor in human urine as osteopontin.
    Sørensen S; Justesen SJ; Johnsen AH
    Urol Res; 1995; 23(5):327-34. PubMed ID: 8839390
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.